Atlas Trials

A Study of TAK-360 in Adults With Narcolepsy Without Cataplexy (NT2)

Clinical trial NCT06952699 · RECRUITING

Trial details

NCT number
NCT06952699
Sponsor
Takeda
Status
RECRUITING
Phase
Phase 2
Study type
INTERVENTIONAL
Narcolepsy Type 2
Start date
2025-05-06
Primary completion
2026-11-30
Enrollment
88

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.